Editorials From a cancer drug fund to value based pricing of drugs BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c4388 (Published 12 August 2010) Cite this as: BMJ 2010;341:c4388 Article Related content Metrics Responses Peer review Related articles Analysis NICE and the challenge of cancer drugs Published: 13 January 2009; BMJ 338 doi:10.1136/bmj.b67 See more NHS rolls out fast tracked immunotherapy for advanced endometrial cancer BMJ March 05, 2024, 384 q557; DOI: https://doi.org/10.1136/bmj.q557 Teledentistry may help in detecting oral cancers in current GP and dentist shortages BMJ March 01, 2024, 384 q512; DOI: https://doi.org/10.1136/bmj.q512 UK’s progress on cancer survival has slowed in past decade, figures show BMJ February 02, 2024, 384 q290; DOI: https://doi.org/10.1136/bmj.q290 NHS rolls out national gene testing to spot cancer risk in Jewish community BMJ February 02, 2024, 384 q283; DOI: https://doi.org/10.1136/bmj.q283 Scarlett McNally: Preventing obesity is different from curing it—and even more urgent BMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134 Cited by... Back to the futureFulltext PDF